| Symbol |
Name |
|
ACVRL1
|
activin A receptor type II-like 1
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
ALKBH4
|
alkB, alkylation repair homolog 4 (E. coli)
|
|
ALKBH5
|
AlkB family member 5, RNA demethylase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
APC
|
adenomatous polyposis coli
|
|
AR
|
androgen receptor
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRD7
|
bromodomain containing 7
|
|
C1GALT1C1
|
C1GALT1-specific chaperone 1
|
|
CASR
|
calcium-sensing receptor
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CD40LG
|
CD40 ligand
|
|
CD70
|
CD70 molecule
|
|
CD8A
|
CD8a molecule
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDX1
|
caudal type homeobox 1
|
|
CITED4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4
|
|
CRABP2
|
cellular retinoic acid binding protein 2
|
|
CRHR2
|
corticotropin releasing hormone receptor 2
|
|
CSAG2
|
CSAG family, member 2
|
|
CTCFL
|
CCCTC-binding factor (zinc finger protein)-like
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
DACT1
|
dishevelled-binding antagonist of beta-catenin 1
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DOT1L
|
DOT1-like histone H3K79 methyltransferase
|
|
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
ERCC5
|
excision repair cross-complementation group 5
|
|
ESR1
|
estrogen receptor 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
FAS
|
Fas cell surface death receptor
|
|
FCER1G
|
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide
|
|
FKBP5
|
FK506 binding protein 5
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXA1
|
forkhead box A1
|
|
FOXP3
|
forkhead box P3
|
|
FTO
|
fat mass and obesity associated
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
HDAC1
|
histone deacetylase 1
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIST1H1E
|
histone cluster 1, H1e
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGB1
|
high mobility group box 1
|
|
HOXA1
|
homeobox A1
|
|
HOXB4
|
homeobox B4
|
|
HR
|
hair growth associated
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFITM3
|
interferon induced transmembrane protein 3
|
|
IFNG
|
interferon, gamma
|
|
IGF2
|
insulin-like growth factor 2
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL6
|
interleukin 6
|
|
ING1
|
inhibitor of growth family, member 1
|
|
INS
|
insulin
|
|
KAT7
|
K(lysine) acetyltransferase 7
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDM2A
|
lysine (K)-specific demethylase 2A
|
|
KDM3A
|
lysine (K)-specific demethylase 3A
|
|
KDM4A
|
lysine (K)-specific demethylase 4A
|
|
KDM4C
|
lysine (K)-specific demethylase 4C
|
|
KDM5A
|
lysine (K)-specific demethylase 5A
|
|
KDM5B
|
lysine (K)-specific demethylase 5B
|
|
KDM6A
|
lysine (K)-specific demethylase 6A
|
|
KDM6B
|
lysine (K)-specific demethylase 6B
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KIAA0226L
|
KIAA0226-like
|
|
KIR2DL4
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
|
|
KLF10
|
Kruppel-like factor 10
|
|
LEP
|
leptin
|
|
MAGEA1
|
melanoma antigen family A1
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MAGEB2
|
melanoma antigen family B2
|
|
MAP2
|
microtubule-associated protein 2
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBD3
|
methyl-CpG binding domain protein 3
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIR126
|
microRNA 126
|
|
MIR128-1
|
microRNA 128-1
|
|
MIR140
|
microRNA 140
|
|
MIR148B
|
microRNA 148b
|
|
MIR152
|
microRNA 152
|
|
MIR17HG
|
miR-17-92 cluster host gene
|
|
MIR193A
|
microRNA 193a
|
|
MIR29A
|
microRNA 29a
|
|
MIR29B1
|
microRNA 29b-1
|
|
MIR29C
|
microRNA 29c
|
|
MIR34B
|
microRNA 34b
|
|
MIR9-3
|
microRNA 9-3
|
|
MLH1
|
mutL homolog 1
|
|
MS4A2
|
membrane-spanning 4-domains, subfamily A, member 2
|
|
MT-ND2
|
MTND2
|
|
MTAP
|
methylthioadenosine phosphorylase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
NANOG
|
Nanog homeobox
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
PADI4
|
peptidyl arginine deiminase, type IV
|
|
PDCD1
|
programmed cell death 1
|
|
PDHA2
|
pyruvate dehydrogenase (lipoamide) alpha 2
|
|
PGK2
|
phosphoglycerate kinase 2
|
|
PLCD1
|
phospholipase C, delta 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRMT5
|
protein arginine methyltransferase 5
|
|
PROM1
|
prominin 1
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1
|
|
RARB
|
retinoic acid receptor, beta
|
|
RASGRF1
|
Ras protein-specific guanine nucleotide-releasing factor 1
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RCOR1
|
REST corepressor 1
|
|
RHOA
|
ras homolog family member A
|
|
RNF4
|
ring finger protein 4
|
|
SBSN
|
suprabasin
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SET
|
SET nuclear proto-oncogene
|
|
SETDB1
|
SET domain, bifurcated 1
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SLC22A4
|
solute carrier family 22 (organic cation/zwitterion transporter), member 4
|
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1)
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SRCAP
|
Snf2-related CREBBP activator protein
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
TARID
|
TCF21 antisense RNA inducing promoter demethylation
|
|
TCF21
|
transcription factor 21
|
|
TDG
|
thymine-DNA glycosylase
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET1
|
tet methylcytosine dioxygenase 1
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TET3
|
tet methylcytosine dioxygenase 3
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TLR3
|
toll-like receptor 3
|
|
TNF
|
tumor necrosis factor
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TOX
|
thymocyte selection-associated high mobility group box
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
UTY
|
ubiquitously transcribed tetratricopeptide repeat containing, Y-linked
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
WIF1
|
WNT inhibitory factor 1
|
